Report Detail

Pharma & Healthcare Global Post Herpetic Neuralgia Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3651437
  • |
  • 07 August, 2019
  • |
  • Global
  • |
  • 104 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Scope of the Report:
The worldwide market for Post Herpetic Neuralgia Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Post Herpetic Neuralgia Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Depomed
Pfizer
Daiichi Sankyo

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Anticonvulsants
Antidepressants
Opioids
Others

Market Segment by Applications, can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Post Herpetic Neuralgia Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Post Herpetic Neuralgia Drugs, with price, sales, revenue and global market share of Post Herpetic Neuralgia Drugs in 2017 and 2018.
Chapter 3, the Post Herpetic Neuralgia Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Post Herpetic Neuralgia Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Post Herpetic Neuralgia Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Post Herpetic Neuralgia Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Post Herpetic Neuralgia Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Anticonvulsants
      • 1.2.2 Antidepressants
      • 1.2.3 Opioids
      • 1.2.4 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital Pharmacies
      • 1.3.2 Online Pharmacies
      • 1.3.3 Retail Pharmacies
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Depomed
      • 2.1.1 Business Overview
      • 2.1.2 Post Herpetic Neuralgia Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Depomed Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Pfizer
      • 2.2.1 Business Overview
      • 2.2.2 Post Herpetic Neuralgia Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Pfizer Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Daiichi Sankyo
      • 2.3.1 Business Overview
      • 2.3.2 Post Herpetic Neuralgia Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Daiichi Sankyo Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Post Herpetic Neuralgia Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Post Herpetic Neuralgia Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Post Herpetic Neuralgia Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Post Herpetic Neuralgia Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Post Herpetic Neuralgia Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Post Herpetic Neuralgia Drugs Market Analysis by Regions

    • 4.1 Global Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Post Herpetic Neuralgia Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Post Herpetic Neuralgia Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)

    5 North America Post Herpetic Neuralgia Drugs by Country

    • 5.1 North America Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
      • 5.1.1 North America Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)

    6 Europe Post Herpetic Neuralgia Drugs by Country

    • 6.1 Europe Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Post Herpetic Neuralgia Drugs by Country

    • 7.1 Asia-Pacific Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2014-2019)
    • 7.2 China Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)

    8 South America Post Herpetic Neuralgia Drugs by Country

    • 8.1 South America Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
      • 8.1.1 South America Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Post Herpetic Neuralgia Drugs by Countries

    • 9.1 Middle East and Africa Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)

    10 Global Post Herpetic Neuralgia Drugs Market Segment by Type

    • 10.1 Global Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Post Herpetic Neuralgia Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Post Herpetic Neuralgia Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Anticonvulsants Sales Growth and Price
      • 10.2.1 Global Anticonvulsants Sales Growth (2014-2019)
      • 10.2.2 Global Anticonvulsants Price (2014-2019)
    • 10.3 Antidepressants Sales Growth and Price
      • 10.3.1 Global Antidepressants Sales Growth (2014-2019)
      • 10.3.2 Global Antidepressants Price (2014-2019)
    • 10.4 Opioids Sales Growth and Price
      • 10.4.1 Global Opioids Sales Growth (2014-2019)
      • 10.4.2 Global Opioids Price (2014-2019)
    • 10.5 Others Sales Growth and Price
      • 10.5.1 Global Others Sales Growth (2014-2019)
      • 10.5.2 Global Others Price (2014-2019)

    11 Global Post Herpetic Neuralgia Drugs Market Segment by Application

    • 11.1 Global Post Herpetic Neuralgia Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Pharmacies Sales Growth (2014-2019)
    • 11.3 Online Pharmacies Sales Growth (2014-2019)
    • 11.4 Retail Pharmacies Sales Growth (2014-2019)

    12 Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)

    • 12.1 Global Post Herpetic Neuralgia Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Post Herpetic Neuralgia Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
    • 12.3 Post Herpetic Neuralgia Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Post Herpetic Neuralgia Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Post Herpetic Neuralgia Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Post Herpetic Neuralgia Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Post Herpetic Neuralgia Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Post Herpetic Neuralgia Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Post Herpetic Neuralgia Drugs. Industry analysis & Market Report on Post Herpetic Neuralgia Drugs is a syndicated market report, published as Global Post Herpetic Neuralgia Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Post Herpetic Neuralgia Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,773.56
      4,160.34
      5,547.12
      3,236.40
      4,854.60
      6,472.80
      532,022.40
      798,033.60
      1,064,044.80
      290,336.40
      435,504.60
      580,672.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report